Bottom line
FHCLX vs JEHSX: the short answer
FHCLX (Health Care Portfolio) and JEHSX (Health Sciences Trust) are both mutual funds.
FHCLX is cheaper at 0.91% vs 1.04% — a difference of $13 a year per $10,000 invested.
Over five years, JEHSX returned +4.2% a year vs +4.0% for FHCLX (reporting dates differ).
Updated Nov 19, 2026
FHCLX vs JEHSX side by side
| FHCLX | JEHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | John Hancock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.91% | 1.04% |
| Annual cost per $10k | $91 | $104 |
| 10-yr cost on $10k (prospectus) | $1,630 | $1,282 |
| Max front load | — | — |
| 12b-1 fee | 0.25% | 0.05% |
| 1-yr return | +14.4% | +19.5% |
| 5-yr return (annualized) | +4.0% | +4.2% |
| 10-yr return (annualized) | +9.0% | +8.7% |
| Best quarter | +22.2% | +23.6% |
| Worst quarter | −15.0% | −16.1% |
| Net assets (fund) | $5.8B | $251.3M |
| Number of holdings | 152 | 173 |
| Portfolio turnover | 69% | 68% |
| Returns as of | Feb 28, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FHCLX | JEHSX | Difference |
|---|---|---|---|
| 2025 | +14.4% | +19.5% | −5.1% |
| 2024 | +4.9% | +1.8% | +3.2% |
| 2023 | +4.1% | +4.3% | −0.1% |
| 2022 | −12.8% | −13.1% | +0.3% |
| 2021 | +11.5% | +11.2% | +0.3% |
| 2020 | +24.4% | +27.2% | −2.7% |
| 2019 | +31.5% | +28.7% | +2.8% |
| 2018 | +7.4% | +0.7% | +6.7% |
| 2017 | +24.0% | +27.5% | −3.5% |
| 2016 | −10.7% | −10.6% | −0.1% |
Source: Fund prospectus bar charts
Holdings overlap
12 of FHCLX's top 25 holdings also appear in JEHSX's top 25.
| Holding | FHCLX | JEHSX |
|---|---|---|
| ELI LILLY and CO | 8.03% | 14.30% |
| Danaher Corp | 6.89% | 1.51% |
| JOHNSON and JOHNSON | 4.91% | 6.33% |
| Thermo Fisher Scientific Inc | 4.33% | 2.67% |
| Unitedhealth Group Inc | 3.49% | 5.95% |
| Gilead Sciences Inc | 2.21% | 2.95% |
| Abbvie Inc | 2.03% | 5.28% |
| MERCK and CO INC | 1.60% | 4.21% |
| Cvs Health Corp | 1.29% | 0.98% |
| Natera Inc | 1.27% | 1.49% |
| Brightspring Health Services Inc | 1.23% | 0.88% |
| Moderna Inc | 1.18% | 0.87% |
Source: SEC Form N-PORT
FHCLX top 10
- ELI LILLY and CO — 8.03%
- Danaher Corp — 6.89%
- JOHNSON and JOHNSON — 4.91%
- Thermo Fisher Scientific Inc — 4.33%
- Unitedhealth Group Inc — 3.49%
- Alnylam Pharmaceuticals Inc — 2.40%
- Gilead Sciences Inc — 2.21%
- Boston Scientific Corp — 2.17%
- Ascendis Pharma A/s — 2.17%
- Fidelity Revere Street Trust — 2.17%
JEHSX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FAQ
What is the difference between FHCLX and JEHSX?
Which is cheaper, FHCLX or JEHSX?
Should I own both FHCLX and JEHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.